We are live on ! Find out more
ALXO icon

ALX Oncology
ALXO

87 hedge funds and large institutions have $410M invested in ALX Oncology in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

833% more call options, than puts

Call options by funds: $252K | Put options by funds: $27K

28% more capital invested

Capital invested by funds: $321M → $410M (+$88.4M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.04% less ownership

Funds ownership: 89.42% → 89.39% (-0.04%)

12% less funds holding

Funds holding: 99 → 87 (-12)

34% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 32

61% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 18

Holders
87
Holders Change
-12
Holders Change %
-12.12%
% of All Funds
1.4%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
21
Reduced
32
Closed
18
Calls
$252K
Puts
$27K
Net Calls
+$225K
Net Calls Change
-$538K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.7M
2
Bank of America
Bank of America
North Carolina
+$2.03M
3
Morgan Stanley
Morgan Stanley
New York
+$1.01M
4
BlackRock
BlackRock
New York
+$345K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$213K

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$6.98M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.34M
3
Millennium Management
Millennium Management
New York
-$1.63M
4
RG
Redmile Group
California
-$1.62M
5
CAM
Cormorant Asset Management
Massachusetts
-$1.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$1.18M -$119K -10,556 -9%
Renaissance Technologies
27
Renaissance Technologies
New York
$1.08M -$840K -74,800 -44%
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$1.01M -$75.6K -6,734 -7%
Millennium Management
29
Millennium Management
New York
$986K -$1.63M -144,716 -62%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$967K -$270K -24,000 -22%
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$958K -$3.34M -297,500 -78%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$785K -$685 -61 -0.1%
TCM
33
Tekla Capital Management
Massachusetts
$746K – – –
Two Sigma Investments
34
Two Sigma Investments
New York
$518K -$681K -60,652 -57%
MAM
35
Martingale Asset Management
Massachusetts
$503K -$34 -3 -0%
Swiss National Bank
36
Swiss National Bank
Switzerland
$485K – – –
NFGH
37
Nan Fung Group Holdings
Hong Kong
$473K – – –
Russell Investments Group
38
Russell Investments Group
United Kingdom
$460K – – –
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$428K +$61.4K +5,467 +17%
CSS
40
Cubist Systematic Strategies
Connecticut
$410K -$94.5K -8,413 -19%
NYLIM
41
New York Life Investment Management
New York
$378K +$42.5K +3,781 +13%
FAG
42
Financial Advisory Group
Texas
$354K – – –
AllianceBernstein
43
AllianceBernstein
Tennessee
$321K +$34.8K +3,100 +12%
AA
44
ALPS Advisors
Colorado
$312K +$61.2K +5,449 +24%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$292K +$7.86K +700 +3%
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
$278K – – –
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$276K +$2.95K +263 +1%
PP
48
PDT Partners
New York
$245K -$164K -14,635 -40%
CS
49
Credit Suisse
Switzerland
$240K -$55.5K -4,940 -19%
BCM
50
Bourgeon Capital Management
Connecticut
$221K – – –
1
2
3 4 5

ALXO Hedge Fund Activity: Q4 2022 in Review

87 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q4 2022, worth a combined $410M — up 28% from $321M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of ALXO and 7 opened new positions — a net loss of 11 holders — while 32 trimmed existing stakes and 21 added.

The largest buyer was Fidelity Investments, adding an estimated $16.7M. The largest seller was Logos Global Management, cutting an estimated $6.98M.

  • 87 institutional investors held ALX Oncology (ALXO) as of Q4 2022, down from 99 in Q3 2022.
  • Funds reported $410M of ALX Oncology stock for Q4 2022, up 28% quarter-over-quarter.
  • 7 funds opened new ALX Oncology positions in Q4 2022 and 18 closed out, a net change of -11 holders.
  • The largest ALX Oncology buyer in Q4 2022 was Fidelity Investments, an estimated $16.7M added.
  • The largest ALX Oncology seller in Q4 2022 was Logos Global Management, an estimated $6.98M sold.

Based on aggregated 13F filings for Q4 2022.